Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study

INTRODUCTION: Our aim in this study was to identify the prevalence and clinical characteristics of LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). METHODS: DNMG patients at 16 sites in the United States were tested for LRP4 and agrin antibodies, and the clinical data were...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivner, Michael H., Quarles, Brandy M., Pan, Jin‐Xiu, Yu, Zheng, Howard, James F., Corse, Andrea, Dimachkie, Mazen M., Jackson, Carlayne, Vu, Tuan, Small, George, Lisak, Robert P., Belsh, Jerry, Lee, Ikjae, Nowak, Richard J., Baute, Vanessa, Scelsa, Stephen, Fernandes, J. Americo, Simmons, Zachary, Swenson, Andrea, Barohn, Richard, Sanka, R. Bhavaraju, Gooch, Clifton, Ubogu, Eroboghene, Caress, James, Pasnoor, Mamatha, Xu, Hongyan, Mei, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496236/
https://www.ncbi.nlm.nih.gov/pubmed/32483837
http://dx.doi.org/10.1002/mus.26985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496236/
https://www.ncbi.nlm.nih.gov/pubmed/32483837
http://dx.doi.org/10.1002/mus.26985

Ejemplares similares